諾和諾德的 CagriSema 2.4 毫克/2.4 毫克在 REIMAGINE 計畫的多項研究中均顯示出顯著降低 HbA1c 和體重的效果。
美國新澤西州普萊恩斯伯勒和丹麥巴格斯沃斯，2026 年 6 月 7 日 /PRNewswire/ -- 諾和諾德 REIMAGINE 1-3 試驗的 3 期結果於今日公佈，結果顯示，2 型糖尿…
该文章暂未提取到完整正文，已从资讯列表和商品关联资讯中自动隐藏。你可以返回文章列表继续浏览其他内容。
常見問題
Which products are related to this article?
No strongly related product has been identified yet. The match updates automatically when the article or catalog changes.
How can I view the medicines discussed in this article?
Use the related product cards below the article to review available specifications, prices, product information, and reviews.
Does this article replace advice from a doctor or pharmacist?
No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.
